DR MAASSARANI & PARTNERS — All Prescriptions & Medications — Page 13
Practice Code: N83608 | LIVERPOOL, L33 1XT
Showing results 601-650 of 687
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 16 | 64 | £70 | -48.6% ▼ | |
| 16 | 325 | £912 | -24.4% ▼ | |
| 16 | 1,082 | £544 | +247.5% ▲ | |
| Naftidrofuryl oxalate | 15 | 1,260 | £148 | -54.0% ▼ |
| Glimepiride | 15 | 420 | £16 | -83.7% ▼ |
| Tafluprost | 15 | 168 | £333 | -19.1% ▼ |
| Salicylic acid | 15 | 179 | £59 | +18.6% ▲ |
| Silver nitrate | 15 | 45 | £193 | +503.3% ▲ |
| 15 | 361 | £911 | +126.3% ▲ | |
| Sucralfate | 14 | 1,958 | £2.4K | +66.7% ▲ |
| Methyldopa | 14 | 1,176 | £1.6K | -17.8% ▼ |
| Pseudoephedrine hydrochloride | 14 | 291 | £68 | +168.8% ▲ |
| Bupropion hydrochloride | 14 | 553 | £367 | +29.5% ▲ |
| Betamethasone sodium phosphate | 14 | 400 | £54 | +13.9% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 14 | 340.0K | £10.3K | +31.5% ▲ |
| Azelastine hydrochloride | 14 | 112 | £85 | +17.8% ▲ |
| Other sunscreening preparations | 14 | 4,375 | £263 | +78.6% ▲ |
| 14 | 250 | £59 | +59.3% ▲ | |
| 14 | 14 | £65 | -72.7% ▼ | |
| Mebeverine hydrochloride compound preparations | 13 | 130 | £113 | +15.0% ▲ |
| Torasemide | 13 | 182 | £63 | +15.8% ▲ |
| Metoprolol tartrate | 13 | 364 | £34 | -74.4% ▼ |
| Enalapril maleate with diuretic | 13 | 364 | £291 | +35.3% ▲ |
| Midodrine hydrochloride | 13 | 1,092 | £287 | -73.3% ▼ |
| Erdosteine | 13 | 728 | £174 | +35.5% ▲ |
| Lofepramine hydrochloride | 13 | 1,092 | £468 | -56.5% ▼ |
| Modafinil | 13 | 1,232 | £86 | -37.7% ▼ |
| Opicapone | 13 | 364 | £717 | -32.1% ▼ |
| Tetrabenazine | 13 | 343 | £370 | -18.0% ▼ |
| Dutasteride | 13 | 364 | £23 | -74.7% ▼ |
| Tacrolimus | 13 | 650 | £970 | -51.4% ▼ |
| Cyproterone acetate | 13 | 728 | £829 | +18.4% ▲ |
| Sodium zirconium cyclosilicate | 13 | 780 | £4.1K | +48.0% ▲ |
| Liquid additive lactase (0913121) | 13 | 217 | £248 | +207.5% ▲ |
| Tube feed 1 kcal/ml with fibre, higher protein (0914011) | 13 | 338.0K | £5.8K | +43.3% ▲ |
| Tafluprost and timolol | 13 | 570 | £276 | -32.3% ▼ |
| Acetylcysteine | 13 | 130 | £1.0K | +28.3% ▲ |
| Acetic acid | 13 | 65 | £61 | +12.2% ▲ |
| 13 | 132 | £44 | -59.8% ▼ | |
| 13 | 425 | £1.2K | -38.5% ▼ | |
| 13 | 24 | £48 | +141.2% ▲ | |
| 13 | 570 | £174 | -55.1% ▼ | |
| 13 | 65 | £151 | +93.9% ▲ | |
| 13 | 960 | £396 | -52.4% ▼ | |
| INR blood testing reagents | 12 | 288 | £820 | +59.3% ▲ |
| Naratriptan hydrochloride | 12 | 138 | £27 | -54.1% ▼ |
| Vigabatrin | 12 | 1,008 | £427 | +10.3% ▲ |
| Apomorphine hydrochloride | 12 | 180 | £5.0K | +8.2% ▲ |
| Cefradine | 12 | 1,324 | £900 | +26.8% ▲ |
| Insulin glulisine | 12 | 60 | £340 | -44.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.